Thyroid Cancer Diagnostics Market Share

Statistics for the 2023 & 2024 Thyroid Cancer Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Thyroid Cancer Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Thyroid Cancer Diagnostics Market Market Share

Market Share of Thyroid Cancer Diagnostics Industry

The thyroid cancer diagnostics market is highly competitive in nature, with many key players dominating the market. The presence of major market players, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., and Generic Electric, is intensifying the competition. The market players are adopting strategies like R&D, mergers, and acquisitions to sustain the increasing market rivalry.

In March 2021, Cancer Genetics and StemoniX announced the news of their merger.

Thyroid Cancer Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Siemens Healthineers

  3. ThermoFisher Scientific

  4. Illumina Inc.

  5. Eli Lilly and Company

*Disclaimer: Major Players sorted in no particular order

Market concentration.png

Thyroid Cancer Diagnostics Report Snapshots

Thyroid Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)